We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $127B Turnover 40.17%
1-Year Est. Return 46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
Cap. Flow
+$9.28B
Cap. Flow %
7.32%
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
2.3 years
Top 20 Avg Time Held Equity + Options
1.6 years
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
2.4 years
Top 20 Avg Time Held Equity only
1.6 years

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$9.86B
2
COST icon
Costco
COST
+$907M
3
ABBV icon
AbbVie
ABBV
+$643M
4
JPM icon
JPMorgan Chase
JPM
+$609M
5
BAC icon
Bank of America
BAC
+$567M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.03B
2
MELI icon
Mercado Libre
MELI
+$528M
3
AVGO icon
Broadcom
AVGO
+$514M
4
SNDK icon
Sandisk
SNDK
+$507M
5
MRVL icon
Marvell Technology
MRVL
+$499M

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.91%
2 Technology 20.64%
3 Consumer Discretionary 9.1%
4 Healthcare 8.21%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALT icon
701
Altimmune
ALT
$449M
$20.8M 0.02%
6,841,055
+2,823,154
+70% +$8.43M
2025 Q4
2 quarters
EPAM icon
702
EPAM Systems
EPAM
$6.28B
$20.7M 0.02%
+260,470
New +$27.5M
2026 Q2
0 quarters
UCTT icon
703
Ultra Clean Holdings
UCTT
$2.43B
$20.6M 0.02%
144,176
-115,676
-45% -$10.2M
2024 Q3
7 quarters
PCOR icon
704
Procore
PCOR
$8.74B
$20.5M 0.02%
505,635
+498,202
+6,703% +$24.6M
2025 Q4
2 quarters
BBIO icon
705
BridgeBio Pharma
BBIO
$13B
$20.5M 0.02%
275,516
-58,866
-18% -$4.12M
2024 Q2
8 quarters
AAL icon
706
American Airlines Group
AAL
$8.18B
$20.5M 0.02%
1,133,478
-5,020,867
-82% -$67.2M
2024 Q1
9 quarters
CSX icon
707
CSX Corp
CSX
$90.9B
$20.4M 0.02%
+430,106
New +$19.4M
2026 Q2
0 quarters
TDY icon
708
Teledyne Technologies
TDY
$29B
$20.3M 0.02%
30,506
+9,526
+45% +$6M
2024 Q4
6 quarters
LGN icon
709
Legence Corp
LGN
$3.5B
$20.3M 0.02%
237,700
+164,547
+225% +$13.4M
2025 Q3
3 quarters
UGI icon
710
UGI
UGI
$8.15B
$20.2M 0.02%
585,364
-1,032,125
-64% -$36.5M
2025 Q4
2 quarters
ERIC icon
711
Ericsson
ERIC
$34.6B
$20.2M 0.02%
1,812,218
+520,645
+40% +$6.28M
2026 Q1
1 quarter
AXS icon
712
AXIS Capital
AXS
$7.19B
$20.2M 0.02%
187,958
-100,102
-35% -$10M
2024 Q3
7 quarters
MRAM icon
713
Everspin Technologies
MRAM
$333M
$20.2M 0.02%
833,578
-30,384
-4% -$681K
2025 Q2
4 quarters
BA icon
714
Boeing
BA
$152B
$20.1M 0.02%
92,649
-502,558
-84% -$112M
2024 Q4
6 quarters
INTC icon
715
CALL
Intel
INTC
$488B
$20M 0.02%
143,100
-761,600
-84% -$77M
2024 Q2
8 quarters
BWXT icon
716
BWX Technologies
BWXT
$12.8B
$20M 0.02%
102,500
+83,718
+446% +$17.4M
2025 Q4
2 quarters
BELFB icon
717
Bel Fuse Inc Class B
BELFB
$3.09B
$19.8M 0.02%
+59,577
New +$16.1M
2026 Q2
0 quarters
ALAB icon
718
Astera Labs
ALAB
$50.1B
$19.8M 0.02%
41,065
-138,485
-77% -$36.7M
2025 Q1
5 quarters
PCG icon
719
PG&E
PCG
$39.2B
$19.8M 0.02%
1,178,287
+1,071,291
+1,001% +$18M
2026 Q1
1 quarter
FRT icon
720
Federal Realty Investment Trust
FRT
$9.25B
$19.7M 0.02%
159,961
-234,640
-59% -$27.3M
2023 Q4
10 quarters
CTRE icon
721
CareTrust REIT
CTRE
$8.64B
$19.7M 0.02%
+488,069
New +$19.2M
2026 Q2
0 quarters
SBLK icon
722
Star Bulk Carriers
SBLK
$3.25B
$19.6M 0.02%
786,668
-430,269
-35% -$11.1M
2025 Q4
2 quarters
EGP icon
723
EastGroup Properties
EGP
$10.5B
$19.6M 0.02%
96,596
-58,894
-38% -$11.8M
2025 Q1
5 quarters
META icon
724
CALL
Meta Platforms (Facebook)
META
$1.84T
$19.5M 0.02%
34,700
+15,100
+77% +$9.23M
2022 Q3
15 quarters
PAYP icon
725
PayPay
PAYP
$10.7B
$19.5M 0.02%
1,361,701
-172,602
-11% -$3.18M
2026 Q1
1 quarter

Similar funds

Marshall Wace's Q2 2026 Portfolio in Review

As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.

  • Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
  • Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
  • Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
  • Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
  • Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
  • Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.